{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:42Z","timestamp":1789964922303,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.leukres.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:00:53Z","timestamp":1483992053000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma"],"prefix":"10.1016","volume":"54","author":[{"given":"Xiaozhou","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Baytak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Okay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genfu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Scuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0005","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0010","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","article-title":"Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center","volume":"13","author":"Johnson","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0015","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","article-title":"Transformation of follicular lymphoma","volume":"24","author":"Lossos","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"11","key":"10.1016\/j.leukres.2017.01.001_bib0020","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3109\/10428194.2014.885513","article-title":"Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis","volume":"55","author":"Mozessohn","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.001_bib0025","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"4706","key":"10.1016\/j.leukres.2017.01.001_bib0030","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.leukres.2017.01.001_bib0035","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1172\/JCI113235","article-title":"Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells","volume":"80","author":"Graninger","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"6189","key":"10.1016\/j.leukres.2017.01.001_bib0040","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0045","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0050","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V87.1.25.25","article-title":"REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma","volume":"87","author":"Houldsworth","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.001_bib0060","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.001_bib0065","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0070","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","article-title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","volume":"113","author":"Cheung","year":"2009","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.leukres.2017.01.001_bib0075","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1158\/1078-0432.CCR-08-0752","article-title":"Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution","volume":"14","author":"d'Amore","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0080","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1046\/j.1365-2141.2000.02352.x","article-title":"The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma","volume":"111","author":"Goff","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.leukres.2017.01.001_bib0085","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.001_bib0090","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"10.1016\/j.leukres.2017.01.001_bib0095","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/1947601911421925","article-title":"The c-Rel transcription factor in development and disease","volume":"2","author":"Gilmore","year":"2011","journal-title":"Genes Cancer"},{"issue":"49","key":"10.1016\/j.leukres.2017.01.001_bib0100","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant rel\/nfkb genes and activity in human cancer","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0105","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yexmp.2015.11.030","article-title":"Over-expression of nuclear NF-kappaB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer","volume":"100","author":"Shuang","year":"2016","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0110","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-2952(03)00250-8","article-title":"Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells","volume":"66","author":"Yeh","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0115","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamcollsurg.2004.04.015","article-title":"Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer","volume":"199","author":"Camp","year":"2004","journal-title":"J. Am. Coll. Surg."},{"issue":"3","key":"10.1016\/j.leukres.2017.01.001_bib0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V75.3.709.709","article-title":"A new human B-cell non-Hodgkin\u2019s lymphoma cell line (Karpas 422) exhibiting both t (14;18) and t(4;11) chromosomal translocations","volume":"75","author":"Dyer","year":"1990","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.leukres.2017.01.001_bib0125","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0165-4608(85)90186-4","article-title":"Histiocytic lymphoma cell lines: immunologic and cytogenetic studies","volume":"14","author":"Hecht","year":"1985","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0130","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ajpath.2012.09.012","article-title":"HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms","volume":"182","author":"Kucuk","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2017.01.001_bib0135","doi-asserted-by":"publisher","first-page":"e898","DOI":"10.1371\/journal.pone.0000898","article-title":"Evidence based selection of housekeeping genes","volume":"2","author":"de Jonge","year":"2007","journal-title":"PLoS One"},{"issue":"Database issue","key":"10.1016\/j.leukres.2017.01.001_bib0140","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.leukres.2017.01.001_bib0145","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","article-title":"Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma","volume":"21","author":"Kucuk","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"43","key":"10.1016\/j.leukres.2017.01.001_bib0150","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.leukres.2017.01.001_bib0155","doi-asserted-by":"publisher","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.leukres.2017.01.001_bib0160","first-page":"1843","article-title":"Structure and autoregulation of the c-rel promoter","volume":"5","author":"Hannink","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2017.01.001_bib0165","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1038\/ncomms6987","article-title":"BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells","volume":"6","author":"Khaled","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0170","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3960\/jslrt.54.31","article-title":"Treatment of follicular lymphoma","volume":"54","author":"Izutsu","year":"2014","journal-title":"J. Clin. Exp. Hematop."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0175","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0027-5107(96)00200-X","article-title":"Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1","volume":"373","author":"Hengstler","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.leukres.2017.01.001_bib0180","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mrfmmm.2014.04.002","article-title":"Activation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes","volume":"763\u2013764","author":"Inturi","year":"2014","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.leukres.2017.01.001_bib0185","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00277-013-1991-y","article-title":"Survival of patients with transformed lymphoma in the rituximab era","volume":"93","author":"Guirguis","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2017.01.001_bib0190","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mrfmmm.2015.01.007","article-title":"Anthracyclines induce double-strand DNA breaks at active gene promoters","volume":"773","author":"Yang","year":"2015","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.leukres.2017.01.001_bib0195","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1182\/blood-2015-01-622084","article-title":"Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12","volume":"126","author":"Kuruvilla","year":"2015","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.leukres.2017.01.001_bib0200","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.leukres.2017.01.001_bib0205","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.4161\/cc.6.18.4721","article-title":"Inhibition of the canonical IKK\/NF kappa B pathway sensitizes human cancer cells to doxorubicin","volume":"6","author":"Tapia","year":"2007","journal-title":"ABBV Cell Cycle"},{"issue":"3","key":"10.1016\/j.leukres.2017.01.001_bib0210","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.leukres.2017.01.001_bib0215","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/sj.onc.1206390","article-title":"Role of NF-kappaB and Akt\/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death","volume":"22","author":"Arlt","year":"2003","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.leukres.2017.01.001_bib0220","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.leukres.2017.01.001_bib0225","doi-asserted-by":"publisher","first-page":"23157","DOI":"10.18632\/oncotarget.4319","article-title":"Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.leukres.2017.01.001_bib0230","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0235","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.leukres.2017.01.001_bib0240","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2017.01.001_bib0245","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.celrep.2015.03.059","article-title":"An oncogenic role for alternative NF-kappaB signaling in DLBCL revealed upon deregulated BCL6 expression","volume":"11","author":"Zhang","year":"2015","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.leukres.2017.01.001_bib0250","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.cdd.4401843","article-title":"Signals from within: the DNA-damage-induced NF-kappaB response","volume":"13","author":"Janssens","year":"2006","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.leukres.2017.01.001_bib0255","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajpath.2013.09.018","article-title":"Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma","volume":"184","author":"Gravelle","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2017.01.001_bib0260","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Marechal","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.leukres.2017.01.001_bib0265","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","article-title":"Brca1 controls homology-directed DNA repair","volume":"4","author":"Moynahan","year":"1999","journal-title":"Mol. Cell."},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2017.01.001_bib0270","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/annonc\/5.suppl_1.S61","article-title":"Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines","volume":"5","author":"Reed","year":"1994","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2017.01.001_bib0275","first-page":"167","article-title":"Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy","volume":"1805","author":"Li","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T19:21:46Z","timestamp":1601320906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":55,"alternative-id":["S0145212617300012"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}